Evaluation of a novel commercial enzyme-linked immunosorbent assay detecting Coxiella burnetii-specific immunoglobulin G for Q fever prevaccination screening and diagnosis.
about
Presence of antibodies against Coxiella burnetii and risk of spontaneous abortion: a nested case-control studyEnzyme-linked immunosorbent assays in seroprevalence studies of Q fever: the need for cut-off adaptation and the consequences for prevalence data.New criteria for immunofluorescence assay for Q fever diagnosis in Japan.No excess risk of adverse pregnancy outcomes among women with serological markers of previous infection with Coxiella burnetii: evidence from the Danish National Birth Cohort.Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis.Evaluation of commonly used serological tests for detection of Coxiella burnetii antibodies in well-defined acute and follow-up seraSeroepidemiologic survey for Coxiella burnetii among US military personnel deployed to Southwest and Central Asia in 2005.The effectiveness of Coxiella burnetii vaccines in occupationally exposed populations: a systematic review and meta-analysis.Comparison of the Q-fever complement fixation test and two commercial enzyme-linked immunosorbent assays for the detection of serum antibodies against Coxiella burnetti (Q-fever) in ruminants : recommendations for use of serological tests on importeSerology in chronic Q fever is still surrounded by question marks.Comparison of two commercially available ELISA antibody test kits for detection of human antibodies against Coxiella burnetii.Immunological arousal during acute Q fever infection.The application of an enzyme-linked immunosorbent assay or an immunofluorescent assay test leads to different estimates of seroprevalence of Coxiella burnetii in the population.Coxiella burnetii and acute exacerbations/infections in patients with chronic lung disease.Clinical features of Q fever pneumonia.Incidence of respiratory pathogens in persons hospitalized with pneumonia in two provinces in Thailand.
P2860
Q28731875-94AE23CC-1321-47BD-9122-B3D01B7D9D55Q31009243-11D0B6E2-8D24-478A-858B-A8F685D48D3CQ34143975-0665A10B-2B20-4D58-8D46-6FCD6F6BD97CQ34588226-14BEF5E9-C534-460E-8427-4A2C38CB4CFEQ35615074-36E702C8-C807-4C0D-A9B9-5D2F156A49C4Q36086276-D4A12B71-68E8-48F9-8A16-594AD4D23260Q37287756-47E8DE93-8FE9-4525-BE7A-461E85B2F4C2Q38110580-65F8828F-3E45-40AC-9B55-9B082576FD04Q38470958-3B05BD22-E622-4B26-9D06-B807D2C73C4DQ40221165-94815909-3E4D-4D42-8B75-6E36F4F37C37Q40294299-C130757D-31FA-4F5C-A068-2EE24AB52FB8Q40327338-81B18B5C-4C7F-437E-B89A-6860A5A584B6Q40334252-DDE667CF-EA67-44C1-9DCE-09E8D67CB419Q40446426-800A5985-73EB-4BC4-950F-1DE261F6F2E3Q40532526-CED43E8E-2FE7-4768-9527-53B3A506B954Q43174250-C9900733-E919-45B7-9B4E-B06652ECD102
P2860
Evaluation of a novel commercial enzyme-linked immunosorbent assay detecting Coxiella burnetii-specific immunoglobulin G for Q fever prevaccination screening and diagnosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2002
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evaluation of a novel commerci ...... ation screening and diagnosis.
@en
Evaluation of a novel commerci ...... ation screening and diagnosis.
@nl
type
label
Evaluation of a novel commerci ...... ation screening and diagnosis.
@en
Evaluation of a novel commerci ...... ation screening and diagnosis.
@nl
prefLabel
Evaluation of a novel commerci ...... ation screening and diagnosis.
@en
Evaluation of a novel commerci ...... ation screening and diagnosis.
@nl
P2093
P2860
P1476
Evaluation of a novel commerci ...... ation screening and diagnosis.
@en
P2093
Alan M Murphy
Avelina Santiago
David Dickeson
Dhara B Patel
Jody L Mitchell
Peter L Devine
Peter R Field
Sau-Wan Chan
P2860
P304
P356
10.1128/JCM.40.9.3526-3529.2002
P407
P577
2002-09-01T00:00:00Z